Hudson Portfolio Management’s GSK GSK Stock Holding History

Hudson Portfolio Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$889K	Sell	16,964 -270	-2%	-$14.3K	0.67%	47
2026 Q1	$951K	Sell	17,234 -1,728	-9%	-$93.6K	0.8%	44
2025 Q4	$930K	Sell	18,962 -1,475	-7%	-$68.8K	0.8%	42
2025 Q3	$882K	Sell	20,437 -207	-1%	-$8.09K	0.78%	41
2025 Q2	$793K	Sell	20,644 -320	-2%	-$12.2K	0.74%	47
2025 Q1	$812K	Sell	20,964 -160	-0.8%	-$5.86K	0.78%	45
2024 Q4	$714K	Sell	21,124 -352	-2%	-$12.7K	0.7%	50
2024 Q3	$878K	Buy	+21,476	New	+$879K	0.86%	38
2023 Q4	$802K	Sell	21,636 -515	-2%	-$18.5K	0.87%	40
2023 Q3	$803K	Hold	22,151	–	–	0.91%	39
2023 Q2	$789K	Hold	22,151	–	–	0.86%	41
2023 Q1	$788K	Hold	22,151	–	–	0.88%	42
2022 Q4	$778K	Buy	+22,151	New	+$738K	0.86%	47
2022 Q3	–	Sell	-22,233	Closed	-$1.21M	–	104
2022 Q2	$1.21M	Sell	22,233 -1,130	-5%	-$62.4K	1.25%	29
2022 Q1	$1.27M	Sell	23,363 -200	-0.8%	-$10.9K	1.12%	31
2021 Q4	$1.3M	Sell	23,563 -1,000	-4%	-$52K	1.15%	29
2021 Q3	$1.17M	Hold	24,563	–	–	1.08%	35
2021 Q2	$1.22M	Sell	24,563 -80	-0.3%	-$3.84K	1.12%	33
2021 Q1	$1.1M	Buy	+24,643	New	+$1.12M	1.06%	31

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Hudson Portfolio Management's GSK Position: Q2 2026 in Review

Hudson Portfolio Management reduced its GSK (GSK) stake by 1.6% in Q2 2026, selling an estimated $14.3K and leaving 16,964 shares worth $889K. The position accounts for 0.67% of the portfolio, ranked #47.

Hudson Portfolio Management first reported a position in GSK in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.3M in Q4 2021. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Hudson Portfolio Management held 16,964 shares of GSK worth $889K as of Q2 2026.
Hudson Portfolio Management sold 270 GSK shares in Q2 2026, an estimated $14.3K.
GSK made up 0.67% of Hudson Portfolio Management's portfolio in Q2 2026, its #47 holding.
Hudson Portfolio Management first reported a position in GSK in Q1 2021 and has held it in 19 quarters since.
Hudson Portfolio Management's GSK position peaked at $1.3M in Q4 2021.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Hudson Portfolio Management's 13F filing for Q2 2026, filed 12 Aug 2026.